Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP)

Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP)

Bibliographic Details
Main Authors:	Staplin, Natalie, Haynes, Richard, Herrington, William G., Reith, Christina, Cass, Alan, Fellström, Bengt, Jiang, Lixin, Kasiske, Bertram L., Krane, Vera, Levin, Adeera, Walker, Robert, Wanner, Christoph, Wheeler, David C., Landray, Martin J., Baigent, Colin, Emberson, Jonathan
Format:	Online
Language:	English
Published:	W.B. Saunders 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4996629/

Similar Items

Evaluating the Contribution of the Cause of Kidney Disease to Prognosis in CKD: Results From the Study of Heart and Renal Protection (SHARP)
by: Haynes, Richard, et al.
Published: (2014)

Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKD
by: Morton, Rachael L., et al.
Published: (2016)

Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP)
by: Mihaylova, Borislava, et al.
Published: (2016)

Evidence for the Prevention and Treatment of Stroke in Dialysis Patients
by: Herrington, William, et al.
Published: (2015)

What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?
by: Kent, Seamus, et al.
Published: (2015)

Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal Protection
by: C. Reith, et al.
Published: (2017-05-01)

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
by: Baigent, Colin, et al.
Published: (2011)

Neprilysin inhibition in chronic kidney disease
by: Judge, Parminder, et al.
Published: (2015)

Estimated Glomerular Filtration Rate and the Risk of Major Vascular Events and All-Cause Mortality: A Meta-Analysis
by: Mafham, Marion, et al.
Published: (2011)

International Network of Chronic Kidney Disease cohort studies (iNET-CKD): a global network of chronic kidney disease cohorts
by: Dienemann, Thomas, et al.
Published: (2016)

CKD273, a New Proteomics Classifier Assessing CKD and Its Prognosis
by: Argilés, Àngel, et al.
Published: (2013)

Prevention and Treatment of CKD-MBD
by: Cozzolino, Mario
Published: (2013)

CKD in disadvantaged populations
by: Guillermo Garcia-Garcia, et al.
Published: (2015-03-01)

CKD in disadvantaged populations
by: Garcia-Garcia, Guillermo, et al.
Published: (2015)

Calcimimetics and outcomes in CKD
by: Drüeke, Tilman B
Published: (2013)

Ockham's razor is not so sharp
by: Lewis, Mark A., et al.
Published: (2010)

Asymptotic Sharpness of Bounds on Hypertrees
by: Lin Yi, et al.
Published: (2017-08-01)

Charles Kirkpatrick Sharpe
by: James B., Caird
Published: (1971)

Association of eGFR-Related Loci Identified by GWAS with Incident CKD and ESRD
by: Böger, Carsten A., et al.
Published: (2011)

The MDRD equation underestimates the prevalence of CKD among blacks and overestimates the prevalence of CKD among whites compared to the CKD-EPI equation: a retrospective cohort study
by: Arora, Pradeep, et al.
Published: (2012)

CKD-MBD after kidney transplantation
by: Wesseling-Perry, Katherine, et al.
Published: (2011)

QT interval in CKD and haemodialysis patients
by: Di Iorio, Biagio, et al.
Published: (2013)

A Japanese approach for CKD-MBD
by: Yokoyama, Keitaro, et al.
Published: (2013)

Chapter 1: Definition and classification of CKD
Published: (2013)

CKD hotspots around the world: announcement
Published: (2014)

Can vascular mortality be reliably ascertained from the underlying cause of death recorded on a medical death certificate? Evidence from 2800 adjudicated heart protection study (HPS) deaths
by: Herrington, William, et al.
Published: (2015)

The dysfunctional endothelium in CKD and in cardiovascular disease: mapping the origin(s) of cardiovascular problems in CKD and of kidney disease in cardiovascular conditions for a research agenda
by: Fliser, Danilo, et al.
Published: (2011)

Diabetic Kidney Disease– A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)
by: Molitch, Mark E., et al.
Published: (2014)

Bias and consistency of the maximum Sharpe ratio
by: Maller, R., et al.
Published: (2005)

FPP and AADK organise SHARP 2016
by: Lee, Feria
Published: (2016)

Matthew Freeman: The sharp end of rhomboids
by: Sedwick, Caitlin
Published: (2014)

On the Edge: Haptic Discrimination of Edge Sharpness
by: Skinner, Andy L., et al.
Published: (2013)

Sharp inequalities for tangent function with applications
by: Hui-Lin Lv, et al.
Published: (2017-05-01)

Stress and Fear of Exposure to Sharps in Nurses
by: Moayed, Malihe Sadat, et al.
Published: (2016)

Sharp Injuries Among Medical Students
by: Ghasemzadeh, Iman, et al.
Published: (2015)

In sharp focus (human resources at Canon)
Published: (2009)

The effects of colestilan versus placebo and sevelamer in patients with CKD 5D and hyperphosphataemia: a 1-year prospective randomized study
by: Locatelli, Francesco, et al.
Published: (2014)

Herbal and dietary supplement use in Thai patients with chronic kidney disease (CKD) and their association with progression of CKD
by: Tangkiatkumjai, Mayuree
Published: (2014)

CKD Express © - A New IT-Software Proposed for a Paradigm Change in CKD Care
by: Onuigbo, Macaulay AC
Published: (2012)

Mechanism-based model characterizing bidirectional interaction between PEGylated liposomal CKD-602 (S-CKD602) and monocytes in cancer patients
by: Wu, Huali, et al.
Published: (2012)